Lisa Egbuonu-Davis, MD, MPH, MBA, Vice President, Global Head of Patient Centered Outcomes and Solutions, Sanofi serves as the strategic lead for promoting and building patient centered products, tools and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs and tools such as patient support programs, as well as creation and development of new mechanisms for improving patient engagement, adherence and outcomes though both internal and external collaborations. Lisa utilizes expertise in data analytics and behavioral science to build patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers. She is particularly focused on improving outcomes in people living with diabetes, cardiovascular disease and other chronic conditions. Lisa is a seasoned pharmaceutical executive with expertise in outcomes research and public health. She has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly. Lisa has a B.S. in Biology at M.I.T. and an M.B.A. in health care management from Wharton; she earned an M.D. and M.P.H. (epidemiology) degrees from Johns Hopkins and is board certified in pediatrics.